High-yield porphyrin production through metabolic engineering and biocatalysis
Haihong Chen,Yaohong Wang,Weishan Wang,Ting Cao,Lu Zhang,Zhengduo Wang,Xuran Chi,Tong Shi,Huangwei Wang,Xinwei He,Mindong Liang,Mengxue Yang,Wenyi Jiang,Dongyuan Lv,Jiaming Yu,Guoliang Zhu,Yongtao Xie,Bei Gao,Xinye Wang,Xueting Liu,Youyuan Li,Limin Ouyang,Jingyu Zhang,Huimin Liu,Zilong Li,Yaojun Tong,Xuekui Xia,Gao-Yi Tan,Lixin Zhang
DOI: https://doi.org/10.1038/s41587-024-02267-3
IF: 46.9
2024-06-06
Nature Biotechnology
Abstract:Porphyrins and their derivatives find extensive applications in medicine, food, energy and materials. In this study, we produced porphyrin compounds by combining Rhodobacter sphaeroides as an efficient cell factory with enzymatic catalysis. Genome-wide CRISPRi-based screening in R. sphaeroide s identifies hemN as a target for improved coproporphyrin III (CPIII) production, and exploiting phosphorylation of PrrA further improves the production of bioactive CPIII to 16.5 g L −1 by fed-batch fermentation. Subsequent screening and engineering high-activity metal chelatases and coproheme decarboxylase results in the synthesis of various metalloporphyrins, including heme and the anti-tumor agent zincphyrin. After pilot-scale fermentation (200 L) and setting up the purification process for CPIII (purity >95%), we scaled up the production of heme and zincphyrin through enzymatic catalysis in a 5-L bioreactor, with CPIII achieving respective enzyme conversion rates of 63% and 98% and yielding 10.8 g L −1 and 21.3 g L −1 , respectively. Our strategy offers a solution for high-yield bioproduction of heme and other valuable porphyrins with substantial industrial and medical applications.
biotechnology & applied microbiology